Give staff comprehensive training in good clinical practice and ethics

October 2007
Clinical Trials Administrator;Oct2007, Vol. 5 Issue 10, p113
The article focuses on good clinical practice (GCP). Brian Bennett of i3, which provides support for drug development, explains that GCP is a set of standards that exists to protect the rights and welfare of subjects participating in research, and to ensure the accuracy of data coming out of the trial. He notes that clinical trial investigators often receive GCP training through industry-sponsored sessions or professional advancement courses or investigator meetings.


Related Articles

  • Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors.  // Annals of Internal Medicine;9/21/2004, Vol. 141 Issue 6, p477 

    This article presents a suggestive note on standards and procedures of clinical trial registration, based on a statement from the International Committee of Medical Journal Editors (ICMJE). The case against selective reporting is particularly compelling for research that tests interventions that...

  • They're Dying to Get In. Bjerklie, David // Time;4/22/2002, Vol. 159 Issue 16, p56 

    Discusses the difficulty of being able to participate in clinical trials in medicine. Benefits of the trials, including substantial doctor-patient interaction; Idea that it is not just the terminally ill who benefit from the attention, but also medically neglected or poorly informed subjects...

  • CHAPTER 26: Design Principles and Their Application in Preventive Field Trials. Brown, C. Hendricks // Handbook of Drug Abuse Prevention: Theory, Science, & Practice;2003, p523 

    The article provides a framework for assessing the quality of a preventive field trial. Such a framework is useful for three purposes. First, research scientists can direct their attention to a limited number of essential elements in designing and implementing new preventive trials. Second,...

  • How to Find a Trial. Smith, Ian K. // Time International (South Pacific Edition);11/22/99, Issue 47, p76 

    Offers information on patient enrollment in clinical drug trials. Researchers' need for patients as well as patients' need for treatment; Reasons adults do not participate in clinical drug trials; Where to locate trials. INSETS: Ace-ing It;Inside Information;Minitel Mini-Stroke;Couch Potatoes...

  • Blinding in clinical trials and other studies. Day, Simon J; Altman, Douglas G // BMJ: British Medical Journal (International Edition);08/19/2000, Vol. 321 Issue 7259, p504 

    Discusses the relevance of allocation concealment, or blinding, in clinical trial practice. Importance of blinding in trials when response criteria is subjective; Difficulties involved in conducting double blind trials; Risk of bias associated with inadequate blinding; Use of blinding in other...

  • Clinical Trial watch.  // Urology Times;1/1/2006, Vol. 34 Issue 1, p25 

    The article presents a list of clinical trials related to urology that were conducted in the U.S. In one of the trials Paciltaxel, Carboplatin and Gemcltabine are used for the Treatment of patients with Advanced Transitional Cell Cancer of the Bladder. In another trial researchers are studying...

  • Retaining Subjects Is Harder Than Recruiting Them. Engfer, Doug // Applied Clinical Trials;Oct2004, Vol. 13 Issue 10, p70 

    The article discusses the difficulty of retention in contrast with recruitment of subjects in clinical trials in the U.S. Percentage of retention rates and dropout rates; Potential benefits of improving retention; Importance of communication and education between the researcher and the subject;...

  • My Life as a Guinea Pig. Reno, Jamie // Newsweek;8/6/2001, Vol. 138 Issue 6, p42 

    Focuses on the author, who participated in a clinical trial that helped preserve him from non-Hodgkin's lymphoma. His participation in a chemotherapy regimen called CHOP; His experiences in a clinical trial of a drug called Bexxar, which put him in remission; View that although clinical trials...

  • Personalized Medicine Development. Newman, Thomas J.; Freitag, Jeffrey J. // Applied Clinical Trials;Jul2011, Vol. 20 Issue 7, p30 

    The article discusses the role of the clinical research organization (CRO) that continues to develop as the popularity of personalized medicine grows in the U.S. It offers an overview of the services offered by CROs in assisting sponsors of personalized clinical trials. Also, it provides...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics